Calton & Associates’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$237K Sell
997
-122
-11% -$25.4K 0.03% 372
2026
Q1
$236K Sell
1,119
-109
-9% -$23.5K 0.03% 382
2025
Q4
$252K Buy
+1,228
New +$231K 0.04% 370
2025
Q3
Sell
-1,207
Closed -$203K 428
2025
Q2
$203K Buy
+1,207
New +$179K 0.04% 366
2018
Q2
Sell
-3,222
Closed -$202K 306
2018
Q1
$202K Sell
3,222
-6,361
-66% -$436K 0.06% 323
2017
Q4
$701K Buy
+9,583
New +$592K 0.18% 108

Other funds holding CAH

Calton & Associates's CAH Position: Q2 2026 in Review

Calton & Associates reduced its Cardinal Health (CAH) stake by 11% in Q2 2026, selling an estimated $25.4K and leaving 997 shares worth $237K. The position accounts for 0.03% of the portfolio, ranked #372.

Calton & Associates first reported a position in CAH in Q4 2017 and has held it in 6 quarters since. The position peaked at $701K in Q4 2017. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Calton & Associates held 997 shares of Cardinal Health worth $237K as of Q2 2026.
  • Calton & Associates sold 122 Cardinal Health shares in Q2 2026, an estimated $25.4K.
  • Cardinal Health made up 0.03% of Calton & Associates's portfolio in Q2 2026, its #372 holding.
  • Calton & Associates first reported a position in Cardinal Health in Q4 2017 and has held it in 6 quarters since.
  • Calton & Associates's Cardinal Health position peaked at $701K in Q4 2017.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Calton & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.